CME Group Inc. (NASDAQ:CME) Shares Sold by Jump Financial LLC

Jump Financial LLC trimmed its position in CME Group Inc. (NASDAQ:CME) by 51.0% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 104,459 shares of the financial services provider’s stock after selling 108,542 shares during the quarter. CME Group makes up 0.5% of Jump Financial LLC’s investment portfolio, making the stock its 24th largest position. Jump Financial LLC’s holdings in CME Group were worth $24,259,000 at the end of the most recent quarter.

Several other institutional investors have also modified their holdings of CME. Ontario Teachers Pension Plan Board lifted its holdings in CME Group by 50.2% during the 4th quarter. Ontario Teachers Pension Plan Board now owns 1,940 shares of the financial services provider’s stock worth $451,000 after buying an additional 648 shares during the last quarter. Guggenheim Capital LLC increased its stake in CME Group by 7.4% in the fourth quarter. Guggenheim Capital LLC now owns 18,603 shares of the financial services provider’s stock valued at $4,320,000 after purchasing an additional 1,283 shares during the last quarter. Aware Super Pty Ltd as trustee of Aware Super acquired a new stake in CME Group during the fourth quarter worth approximately $2,086,000. Canada Post Corp Registered Pension Plan acquired a new stake in CME Group during the fourth quarter worth approximately $7,925,000. Finally, CreativeOne Wealth LLC boosted its holdings in shares of CME Group by 24.1% in the 4th quarter. CreativeOne Wealth LLC now owns 10,410 shares of the financial services provider’s stock valued at $2,417,000 after buying an additional 2,021 shares in the last quarter. 87.75% of the stock is owned by hedge funds and other institutional investors.

CME Group Stock Up 0.8 %

CME Group stock opened at $263.69 on Tuesday. The firm has a market capitalization of $95.02 billion, a price-to-earnings ratio of 27.27, a price-to-earnings-growth ratio of 6.76 and a beta of 0.43. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.02 and a current ratio of 1.01. CME Group Inc. has a fifty-two week low of $190.70 and a fifty-two week high of $273.42. The stock’s fifty day moving average is $255.66 and its two-hundred day moving average is $239.56.

CME Group (NASDAQ:CME) last announced its quarterly earnings data on Wednesday, February 12th. The financial services provider reported $2.52 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.46 by $0.06. CME Group had a net margin of 57.52% and a return on equity of 13.62%. Analysts predict that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, March 26th. Stockholders of record on Friday, March 7th were given a $1.25 dividend. The ex-dividend date was Friday, March 7th. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.90%. This is an increase from CME Group’s previous quarterly dividend of $1.15. CME Group’s payout ratio is currently 51.71%.

Insider Activity at CME Group

In related news, Director Howard J. Siegel sold 10,000 shares of the company’s stock in a transaction that occurred on Thursday, March 13th. The shares were sold at an average price of $260.00, for a total transaction of $2,600,000.00. Following the completion of the transaction, the director now owns 21,873 shares of the company’s stock, valued at approximately $5,686,980. This represents a 31.37 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Julie Winkler sold 11,592 shares of the company’s stock in a transaction on Thursday, February 13th. The stock was sold at an average price of $249.17, for a total value of $2,888,378.64. Following the sale, the insider now owns 21,885 shares of the company’s stock, valued at approximately $5,453,085.45. The trade was a 34.63 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 27,076 shares of company stock worth $6,871,496. 0.30% of the stock is currently owned by insiders.

Analysts Set New Price Targets

Several analysts have recently weighed in on CME shares. Bank of America boosted their target price on CME Group from $200.00 to $219.00 and gave the company an “underperform” rating in a report on Wednesday, April 2nd. JPMorgan Chase & Co. increased their price target on shares of CME Group from $209.00 to $212.00 and gave the stock an “underweight” rating in a research note on Thursday, February 13th. Keefe, Bruyette & Woods upped their target price on shares of CME Group from $256.00 to $257.00 and gave the company a “market perform” rating in a report on Friday, February 14th. Piper Sandler increased their price objective on CME Group from $275.00 to $283.00 and gave the stock an “overweight” rating in a research report on Tuesday, April 8th. Finally, Barclays boosted their target price on CME Group from $263.00 to $279.00 and gave the company an “equal weight” rating in a report on Monday, April 7th. Four equities research analysts have rated the stock with a sell rating, seven have given a hold rating, four have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $247.47.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.